Barrow, Hanley, Mewhinney & Strauss’s Novanta NOVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NOVT
Barrow, Hanley, Mewhinney & Strauss's NOVT Position: Q2 2026 in Review
Barrow, Hanley, Mewhinney & Strauss increased its Novanta (NOVT) stake by 7% in Q2 2026, buying an estimated $4.14M and bringing the position to 440,131 shares worth $71.4M. The position accounts for 0.22% of the portfolio, ranked #101.
Barrow, Hanley, Mewhinney & Strauss first reported a position in NOVT in Q3 2016 and has held it in 6 quarters since. 391 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss held 440,131 shares of Novanta worth $71.4M as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss bought 28,617 Novanta shares in Q2 2026, an estimated $4.14M.
- Novanta made up 0.22% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #101 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Novanta in Q3 2016 and has held it in 6 quarters since.
- 391 funds tracked by Wall St. Rank held Novanta as of Q2 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.